![](/img/cover-not-exists.png)
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease
Daniel A. Anaya, Yan Xing, Lei Feng, Xuelin Huang, Luis H. Camacho, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Paul F. Mansfield, Janice N. CormierVolume:
112
Year:
2008
Language:
english
Pages:
8
DOI:
10.1002/cncr.23399
File:
PDF, 104 KB
english, 2008